BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11972876)

  • 1. Genetic predispositions for the presence of cryoglobulinemia and serum autoantibodies in Chinese patients with chronic hepatitis C.
    Hwang SJ; Chu CW; Huang DF; Lan KH; Chang FY; Lee SD
    Tissue Antigens; 2002 Jan; 59(1):31-7. PubMed ID: 11972876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia.
    Cacoub P; Renou C; Kerr G; Hüe S; Rosenthal E; Cohen P; Kaplanski G; Charlotte F; Thibault V; Ghillani P; Piette JC; Caillat-Zucman S
    Arthritis Rheum; 2001 Sep; 44(9):2118-24. PubMed ID: 11592376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are HLA class II and immunoglobulin constant region genes involved in the pathogenesis of mixed cryoglobulinemia type II after hepatitis C virus infection?
    Amoroso A; Berrino M; Canale L; Cornaglia M; Guarrera S; Mazzola G; Savoldi S; Scolari F; Sällberg M; Clementi M; Gabrielli A
    J Hepatol; 1998 Jul; 29(1):36-44. PubMed ID: 9696490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haplotype HLA-B8-DR3 confers susceptibility to hepatitis C virus-related mixed cryoglobulinemia.
    Lenzi M; Frisoni M; Mantovani V; Ricci P; Muratori L; Francesconi R; Cuccia M; Ferri S; Bianchi FB
    Blood; 1998 Mar; 91(6):2062-6. PubMed ID: 9490691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of a genetic basis for the different geographic occurrences of liver/kidney microsomal antibody type 1 in hepatitis C.
    Muratori P; Czaja AJ; Muratori L; Granito A; Guidi M; Ferri S; Volta U; Mantovani W; Pappas G; Cassani F; Lenzi M; Bianchi FB
    Dig Dis Sci; 2007 Jan; 52(1):179-84. PubMed ID: 17160474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA class II genes in chronic hepatitis C virus-infection and associated immunological disorders.
    Congia M; Clemente MG; Dessi C; Cucca F; Mazzoleni AP; Frau F; Lampis R; Cao A; Lai ME; De Virgiliis S
    Hepatology; 1996 Dec; 24(6):1338-41. PubMed ID: 8938157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C.
    Zavaglia C; Martinetti M; Silini E; Bottelli R; Daielli C; Asti M; Airoldi A; Salvaneschi L; Mondelli MU; Ideo G
    J Hepatol; 1998 Jan; 28(1):1-7. PubMed ID: 9537846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased frequency of the HLA-DRB1*11 allele in patients with chronic hepatitis C virus infection.
    Yenigün A; Durupinar B
    J Virol; 2002 Feb; 76(4):1787-9. PubMed ID: 11799174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia.
    Cramp ME; Carucci P; Underhill J; Naoumov NV; Williams R; Donaldson PT
    J Hepatol; 1998 Aug; 29(2):207-13. PubMed ID: 9722201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological markers of autoimmunity in renal transplant patients with chronic hepatitis C.
    Rostaing L; Modesto A; Cisterne JM; Izopet J; Oksman F; Duffaut M; Abbal M; Durand D
    Am J Nephrol; 1998; 18(1):50-6. PubMed ID: 9481439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating anti-HLA antibodies in patients with chronic hepatitis C: relation to disease activity.
    El Aggan HA; Sidkey F; El Gezery DA; Ghoneim E
    Egypt J Immunol; 2004; 11(2):71-9. PubMed ID: 16734119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA DR-DQ combination associated with the increased risk of developing human HCV positive non-Hodgkin's lymphoma is related to the type II mixed cryoglobulinemia.
    De Re V; Caggiari L; Monti G; Libra M; Spina M; Dolcetti R; De Zorzi M; Racanelli V; Crovatto M; Toffoli G
    Tissue Antigens; 2010 Feb; 75(2):127-35. PubMed ID: 20002609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA class II alleles and chronic hepatitis C virus infection.
    Cangussu LOF; Teixeira R; Campos EF; Rampim GF; Mingoti SA; Martins-Filho OA; Gerbase-DeLima M
    Scand J Immunol; 2011 Sep; 74(3):282-287. PubMed ID: 21535077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of the human leukocyte antigen class II alleles in Brazilian patients with chronic hepatitis C virus infection.
    Corghi DB; Gonçales NS; Marques SB; Gonçales FL
    Braz J Med Biol Res; 2008 Oct; 41(10):884-9. PubMed ID: 18925312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic predispositions for immunological features in chronic liver diseases other than autoimmune hepatitis.
    Czaja AJ; Carpenter HA; Santrach PJ; Moore SB
    J Hepatol; 1996 Jan; 24(1):52-9. PubMed ID: 8834025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DR5 antigen. A genetic factor influencing the outcome of hepatitis C virus infection?
    Peano G; Menardi G; Ponzetto A; Fenoglio LM
    Arch Intern Med; 1994 Dec 12-26; 154(23):2733-6. PubMed ID: 7993158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DQ associations in type 1 autoimmune hepatitis.
    Czaja AJ; Santrach PJ; Moore SB
    Mayo Clin Proc; 1995 Dec; 70(12):1154-60. PubMed ID: 7490916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-A, B, DR, and DQ antigens in Indian patients with severe chronic rheumatic heart disease.
    Maharaj B; Khedun SM; Hammond MG; van der Byl K
    Jpn Heart J; 1997 Sep; 38(5):663-8. PubMed ID: 9462415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Viral genotype and HLA class II alleles influence on extra-hepatic manifestations of chronic HCV infection].
    Giannitti C; Morozzi G; D'Alfonso S; Bellisai F; Galeazzi M
    Reumatismo; 2008; 60(3):192-8. PubMed ID: 18854880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterozygote advantage for HLA class-II type in hepatitis B virus infection.
    Thursz MR; Thomas HC; Greenwood BM; Hill AV
    Nat Genet; 1997 Sep; 17(1):11-2. PubMed ID: 9288086
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.